Earnings History Data for OptiNose, Inc. (OPTN) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
OptiNose, Inc.
OptiNose Inc. is a specialty pharmaceutical company. It focused on the development and commercialization of products for patients treated by ear, nose and throat or ENT and allergy specialists. The company's lead product consists of XHANCE nasal polyps, XHANCE Chronic sinusitis, OPN-300, OPN- 021 and AVP-825 which are in clinical stage. OptiNose Inc. is headquartered in Pennsylvania, USA.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 07-03-2024 | PM | OPTN | OptiNose, Inc. | 193.74 | -0.09 | -0.10 | -0.17 | OptiNose reports mixed results; initiates Q1 and FY24 outlook [3/7/2024 7:12 AM] |
1.71 | -0.04 (-2.29%) |
1.73 | -0.02 (-1.14%) |
0.90 - 2.07 | 302,075 | 620,000 | 47,181 | ||
| 09-11-2023 | PM | OPTN | OptiNose, Inc. | 135.79 | -0.08 | -0.10 | -0.18 | OptiNose GAAP EPS of -$0.08, revenue of $19.8M [11/9/2023 7:08 AM] |
1.22 | -0.02 (-1.61%) |
1.30 | 0.06 (4.84%) |
0.90 - 3.47 | 266,224 | 230,000 | 4,219 | ||
| 10-08-2023 | PM | OPTN | OptiNose, Inc. | 137.71 | 0.02 | -0.11 | -0.23 | OptiNose GAAP EPS of $0.02 beats by $0.13, revenue of $19.45M beats by $2.45M [8/10/2023 7:02 AM] |
1.24 | 0.08 (6.90%) |
1.29 | 0.13 (11.21%) |
0.90 - 4.30 | 570,848 | 330,000 | 8,317 | ||
| 11-05-2023 | PM | 7:00 AM ET (May 11) |
OPTN | OptiNose, Inc. | 204.61 | -0.17 | -0.16 | -0.31 | OptiNose GAAP EPS of -$0.17, revenue of $11.85M [5/11/2023 7:02 AM] |
1.99 | 0.13 (6.99%) |
0.0 | 0.0 (0.00%) |
1.55 - 4.30 | 205,052 | 130,000 | 0 | |
| 07-03-2023 | PM | 7:00 AM ET (Mar 7) |
OPTN | OptiNose, Inc. | 188.24 | -0.17 | -0.16 | -0.23 | OptiNose GAAP EPS of -$0.17 in-line, revenue of $20.86M beats by $0.17M [3/7/2023 7:03 AM] |
1.86 | -0.04 (-2.11%) |
1.70 | -0.20 (-10.53%) |
1.55 - 4.30 | 274,919 | 70,000 | 2,515 | |
| 10-11-2022 | PM | 7:00 AM ET (Nov 10) |
OPTN | OptiNose, Inc. | 288.97 | -0.18 | -0.17 | -0.32 | OptiNose reports mixed Q3 earnings; narrows FY22 guidance range [11/10/2022 7:07 AM] |
2.75 | -0.50 (-15.38%) |
2.99 | -0.26 (-8.00%) |
1.46 - 4.30 | 262,607 | 30,000 | 3,740 | |
|
||||||||||||||||||
| 11-08-2022 | PM | 7:00 AM ET (Aug 11) |
OPTN | OptiNose, Inc. | 293.52 | -0.23 | -0.22 | -0.44 | OptiNose GAAP EPS of -$0.23 beats by $0.01, revenue of $20.6M misses by $0.9M [8/11/2022 7:07 AM] |
3.57 | -0.13 (-3.51%) |
0.0 | 0.0 (0.00%) |
1.46 - 4.14 | 87,074 | 150,000 | 0 | |
| 12-05-2022 | PM | 7:00 AM ET (May 12) |
OPTN | OptiNose, Inc. | 161.23 | -0.31 | -0.24 | -0.49 | OptiNose GAAP EPS of -$0.31, revenue of $14.76M; issues FY22 guidance [5/12/2022 7:06 AM] |
1.76 | -0.10 (-5.38%) |
0.0 | 0.0 (0.00%) |
1.46 - 3.85 | 122,777 | 200,000 | 0 | |
| 08-03-2022 | PM | Before the open (Mar 8) |
OPTN | OptiNose, Inc. | 223.58 | -0.23 | -0.22 | -0.46 | OptiNose GAAP EPS of -$0.23 beats by $0.03, revenue of $22.51M beats by $0.76M [3/8/2022 7:14 AM] |
2.59 | -0.16 (-5.82%) |
0.0 | 0.0 (0.00%) |
1.46 - 4.03 | 402,156 | 360,000 | 0 | |
|
||||||||||||||||||
| 11-08-2021 | PM | 7:00 AM ET (Aug 11) |
OPTN | OptiNose, Inc. | 142.34 | -0.44 | -0.43 | -0.56 | OptiNose EPS misses by $0.02, misses on revenue [8/11/2021 7:27 AM] |
2.35 | -0.31 (-11.65%) |
2.75 | 0.09 (3.38%) |
2.32 - 7.04 | 1,131,304 | 310,000 | 13,139 | |
| 05-05-2021 | PM | 7:00 AM ET (May 5) |
OPTN | OptiNose, Inc. | 189.02 | -0.49 | -0.51 | -0.63 | OptiNose EPS beats by $0.03, beats on revenue [5/5/2021 7:14 AM] |
3.23 | -0.07 (-2.12%) |
3.23 | 0.0 (0.00%) |
3.14 - 10.00 | 449,549 | 270,000 | 8,259 | |
| 03-03-2021 | PM | 7:00 AM ET (Mar 3) |
OPTN | OptiNose, Inc. | 208.84 | -0.46 | -0.45 | -0.58 | OptiNose EPS misses by $0.01, misses on revenue; updates FY21 outlook [3/3/2021 7:06 AM] |
3.82 | -0.10 (-2.68%) |
4.07 | 0.15 (3.83%) |
3.14 - 10.00 | 1,402,232 | 502,524 | 209,295 | |
|
||||||||||||||||||
| 05-11-2020 | PM | 7:00 AM ET (Nov 5) |
OPTN | OptiNose, Inc. | 194.45 | -0.43 | -0.56 | -0.69 | OptiNose EPS beats by $0.06, beats on revenue [11/5/2020 7:11 AM] |
3.95 | 0.40 (11.42%) |
3.95 | 0.0 (0.00%) |
3.14 - 11.66 | 394,674 | 438,689 | 2,117 | |
|
|
||||||||||||||||||
| 04-08-2020 | PM | 6:30 AM ET (Aug 4) |
OPTN | OptiNose, Inc. | 233.89 | -0.56 | -0.51 | -0.66 | OptiNose EPS in-line, beats on revenue [8/4/2020 7:05 AM] |
6.35 | 0.64 (11.21%) |
5.79 | 0.08 (1.40%) |
3.28 - 11.66 | 546,067 | 374,484 | 2,929 | |
|
|
||||||||||||||||||